TAK-085

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
012320112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The effects of cholesterol-lowering statins, which substantially benefit future cardiovascular events, on fatty acid metabolism… (More)
Is this relevant?
2015
2015
BACKGROUND Low-density lipoproteins (LDLs) comprise a heterogeneous group of particles with various size and density. A shift to… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2015
2015
We investigated whether a highly purified eicosapentaenoic acid (EPA) and a concentrated n-3 fatty acid formulation (prescription… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2014
2014
The omega-3 polyunsaturated fatty acids (ω-3 PUFAs) docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) protect against… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2013
2013
BACKGROUND TAK-085 is an omega-3 preparation that contains eicosapentaenoic acid ethyl-ester (EPA-E) and docosahexaenoic acid… (More)
Is this relevant?
2013
2013
BACKGROUND Hypertriglyceridemia is a risk factor for cardiovascular disease, and clinical practice guidelines advocate treatment… (More)
Is this relevant?
2013
2013
Metabolic syndrome is implicated in the decline of cognitive ability. We investigated whether the prescription n-3 fatty acid… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Deposition of amyloid β peptide (Aβ) into the brain causes cognitive impairment. We investigated whether prescription pre… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?